Literature DB >> 2693890

Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy.

Y Sakaki1, K Yoshioka, H Tanahashi, H Furuya, H Sasaki.   

Abstract

Transthyretin (TTR, also called prealbumin) is a plasma protein produced in liver. The variant types of TTR are known to be closely associated with familial amyloidotic polyneuropathy (FAP), an autosomal dominant genetic disorder. This article summarizes, together with some new data, our current knowledge on FAP from the view point of molecular genetics. As an initial step towards understanding the disease at the DNA level, the complete nucleotide sequence of the human TTR gene (-7 kb to 7 kb; 1 kb = 10(3) bases) was determined and analyzed. The gene is located on chromosome 18 q12.1 and consists of four exons. Homology search revealed that there exist several possible regulatory signals in the 5' flanking region of the gene, including the binding sites for liver-specific nuclear factors HNF-1, 3, 4 and C/E BP, which have been previously identified in mouse TTR gene. Sequence analysis enabled us to identify all the mutations related to various types of FAP. The mutations were shown to be almost completely linked to FAP and it has become possible to diagnose FAP even at presymptomatic (prenatal) stages by recombinant DNA technology, with a high reliability. Haplotype analysis of FAP families using DNA polymorphic markers in the TTR locus suggested that the Val30----Met mutation closely related to type I FAP, the most common type of FAP, has frequently recurred in the human population to generate FAP families of independent origin. Although the primary cause of FAP has become clear, extensive screening of FAP families in various locations suggested that the expression of FAP is a complicated process and affected by some unknown factors (other than TTR).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693890

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  6 in total

1.  Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).

Authors:  Jacquelyn L Sikora; Mark W Logue; Gloria G Chan; Brian H Spencer; Tatiana B Prokaeva; Clinton T Baldwin; David C Seldin; Lawreen H Connors
Journal:  Hum Genet       Date:  2014-11-04       Impact factor: 4.132

2.  A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.

Authors:  M D Benson; J C Turpin; G Lucotte; S Zeldenrust; B LeChevalier; M D Benson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

3.  Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14.

Authors:  P St George-Hyslop; E Rogaeva; J Huterer; T Tsuda; J Santos; J L Haines; K Schlumpf; E I Rogaev; Y Liang; D R McLachlan
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

4.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

5.  Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.

Authors:  Mika Ohta; Aki Sugano; Naoya Hatano; Hirotaka Sato; Hirofumi Shimada; Hitoshi Niwa; Toshiyuki Sakaeda; Hajime Tei; Yoshiyuki Sakaki; Ken-Ichi Yamamura; Yutaka Takaoka
Journal:  Transgenic Res       Date:  2017-12-29       Impact factor: 2.788

6.  Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.

Authors:  Selina Hein; Jennifer Furkel; Maximilian Knoll; Fabian Aus dem Siepen; Stefan Schönland; Ute Hegenbart; Hugo A Katus; Arnt V Kristen; Mathias H Konstandin
Journal:  Clin Res Cardiol       Date:  2021-01-22       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.